PharmNovo
SwedenEntry
2020
Hold
6yr
Status
Active
Who owns PharmNovo?
PharmNovo is a Swedish Biotech company, currently owned by Karolinska Development since 2022 and Almi Invest.
Hand-verified · updated 2026-08-17
Open JSON · CC-BY
Most recent investor
Almi InvestAlmi Invest (Regional funds) · 2009 · VC
2 ownership periods · full history below
Key facts
HQSweden
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2020 · present
Almi InvestActive
2020 · present(6yr) · Almi Invest (Regional funds) · 2009 · VC
Karolinska DevelopmentActive
2022 · present(4yr) · Karolinska Development · 2003 · Life Sciences VC
More from Almi Invest (Regional funds)
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns PharmNovo?
PharmNovo is currently owned by Karolinska Development and Almi Invest, through Almi Invest (Regional funds), since 2022.
When did Karolinska Development and 1 other acquire PharmNovo?
Karolinska Development and 1 other acquired PharmNovo in 2022.
Who has owned PharmNovo over time?
PharmNovo has been through 2 private-equity ownership periods: Almi Invest · via Almi Invest (Regional funds) · since 2020; Karolinska Development · via Karolinska Development · since 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue